Department of Medicine;
King Faisal Specialist Hospital;
Research Centre;
Al Faisal University;
Riyadh 12713;
Saudi Arabia;
Hurthle cell thyroid cancer; Lenvatinib; Nephrotic syndrome; Vascular endothelial growth factor; Protein kinase inhibitors; Kidney neoplasms/secondary neoplasm; Case report;